Related references
Note: Only part of the references are listed.TERT Promoter Mutations and Their Association with BRAF V600E Mutation and Aggressive Clinicopathological Characteristics of Thyroid Cancer
Xiaoli Liu et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
TERT Promoter Mutations Are a Major Indicator of Poor Outcome in Differentiated Thyroid Carcinomas
Miguel Melo et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
BRAF V600E and TERT Promoter Mutations Cooperatively Identify the Most Aggressive Papillary Thyroid Cancer With Highest Recurrence
Mingzhao Xing et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Frequent somatic mutations of the telomerase reverse transcriptase promoter in ovarian clear cell carcinoma but not in other major types of gynaecological malignancy
Ren-Chin Wu et al.
JOURNAL OF PATHOLOGY (2014)
The age- and shorter telomere-dependent TERT promoter mutation in follicular thyroid cell-derived carcinomas
T. Liu et al.
ONCOGENE (2014)
Telomerase promoter mutations in cancer: an emerging molecular biomarker?
Joao Vinagre et al.
VIRCHOWS ARCHIV (2014)
Current Thyroid Cancer Trends in the United States
Louise Davies et al.
JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY (2014)
Upregulating mutations in the TERT promoter commonly occur in adult malignant gliomas and are strongly associated with total 1p19q loss
Hideyuki Arita et al.
ACTA NEUROPATHOLOGICA (2013)
TERT Promoter Mutations Occur Early in Urothelial Neoplasia and Are Biomarkers of Early Disease and Disease Recurrence in Urine
Isaac Kinde et al.
CANCER RESEARCH (2013)
Highly prevalent TERT promoter mutations in bladder cancer and glioblastoma
Xiaoli Liu et al.
CELL CYCLE (2013)
Highly prevalent TERT promoter mutations in aggressive thyroid cancers
Xiaoli Liu et al.
ENDOCRINE-RELATED CANCER (2013)
Overdiagnosis and Overtreatment in Cancer An Opportunity for Improvement
Laura J. Esserman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Allele Percentage of the BRAF V600E Mutation in Papillary Thyroid Carcinomas and Corresponding Lymph Node Metastases: No Evidence for a Role in Tumor Progression
Greta Gandolfi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Frequent Somatic TERT Promoter Mutations in Thyroid Cancer: Higher Prevalence in Advanced Forms of the Disease
Inigo Landa et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
TERT promoter mutations in bladder cancer affect patient survival and disease recurrence through modification by a common polymorphism
P. Sivaramakrishna Rachakonda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
Patrick J. Killela et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
TERT Promoter Mutations in Familial and Sporadic Melanoma
Susanne Horn et al.
SCIENCE (2013)
Highly Recurrent TERT Promoter Mutations in Human Melanoma
Franklin W. Huang et al.
SCIENCE (2013)
BRAFV600E Mutation Does Not Mean Distant Metastasis in Thyroid Papillary Carcinomas
Valentina Sancisi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
BRAF V600E mutation and Its Association with Clinicopathological Features of Papillary Thyroid Cancer: A Meta-Analysis
Carol Li et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Molecular prognostic markers in papillary and follicular thyroid cancer: Current status and future directions
Dada Handkiewicz-Junak et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2010)
Dissecting the non-canonical functions of telomerase
E. K. Parkinson et al.
CYTOGENETIC AND GENOME RESEARCH (2008)
The biogenesis and regulation of telomerase holoenzymes
Kathleen Collins
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Increasing incidence of thyroid cancer in the United States, 1973-2002
L Davies et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Pathogenetic mechanisms in thyroid follicular-cell neoplasia
T Kondo et al.
NATURE REVIEWS CANCER (2006)
Telomerase: not just for the elongation of telomeres
RT Calado et al.
BIOESSAYS (2006)
Involvement of hTERT in apoptosis induced by interference with Bcl-2 expression and function
D Del Bufalo et al.
CELL DEATH AND DIFFERENTIATION (2005)
Differentiated thyroid carcinoma with distant metastases at presentation: prognostic factors and outcome
M Haq et al.
CLINICAL ENDOCRINOLOGY (2005)
The telomerase reverse transcriptase regulates chromatin state and DNA damage responses
K Masutomi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
hTERT antagonizes p53-induced apoptosis independently of telomerase activity
R Rahman et al.
ONCOGENE (2005)
Share Paper
